Josée Golay, Greta Ubiali and Martino Introna (2017) “The specific Bruton tyrosine kinase inhibitor acalabrutinib (ACP-196) shows favorable in vitro activity against chronic lymphocytic leukemia B cells with CD20 antibodies”, Haematologica. Pavia, Italy, 102(10), pp. e400-e403. doi: 10.3324/haematol.2017.169334.